Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
i decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
i decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
301
-
302
-
303
-
304
-
305
-
306
-
307
-
308
-
309
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
Published 2024“…As CWP progressed, the CC and CA genotypes of <i>ERCC1</i> rs3212986 decreased and increased significantly, respectively. …”
-
310
-
311
-
312
-
313
-
314
-
315
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025“…Kinetic fluorescence and PAI curves were evaluated to determine the effects of the ABY-029 dose and EGFR blocking on tumor RA estimation. Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”
-
316
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025“…Kinetic fluorescence and PAI curves were evaluated to determine the effects of the ABY-029 dose and EGFR blocking on tumor RA estimation. Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”
-
317
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025“…Kinetic fluorescence and PAI curves were evaluated to determine the effects of the ABY-029 dose and EGFR blocking on tumor RA estimation. Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”
-
318
-
319
Participant retention flowchart.
Published 2025“…We used latent class and latent transition analysis to identify subtypes at baseline, determined their consistency at 6- and 12-month follow-ups, and examined transitions over time. We identified a 4-class solution: (1) severe with appetite decrease, (2) severe with appetite increase, (3) moderate severity and (4) low severity. …”
-
320